This inventor holds 2 USPTO granted patents. Top assignees: Glaxo Laboratories Limited, Glaxo Operations UK Limited. Active years: 1980-1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1981
Title: The Innovations of Nigel S. Watson
Introduction
Nigel S. Watson is a notable inventor based in Greenford, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds with antibiotic properties. With a total of two patents to his name, Watson's work has implications for the synthesis of important pharmaceutical compounds.
Latest Patents
Watson's latest patents include the disclosure of esters of 2-vinylclav-2-em-3-carboxylic acid and processes for preparing 2-vinylclavem compounds. These compounds have been found valuable in the synthesis of thio-derivatives of clavulanic acid, which possess antibiotic and beta-lactamase inhibitory activity. The methods for preparing these vinylclavem compounds are detailed, along with processes for creating the thio-derivatives. Additionally, Watson has disclosed azetidinone derivatives, which are beta-lactam compounds that serve as valuable intermediates for the preparation or purification of further beta-lactam compounds with beta-lactamase inhibitory activity.
Career Highlights
Throughout his career, Nigel S. Watson has worked with prominent companies in the pharmaceutical industry, including Glaxo Laboratories Limited and Glaxo Operations UK Limited. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.
Collaborations
Watson has collaborated with notable colleagues such as Peter C. Cherry and Christopher Earle Newall. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
Nigel S. Watson's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile